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Abstract
Background: Ankle-brachial index (ABI) can access peripheral artery disease and predict mortality in prevalent patients on
hemodialysis. However, ABI has not yet been tested in incident patients, who present significant mortality. Typically, ABI is
measured by Doppler, which is not always available, limiting its use in most patients. We therefore hypothesized that ABI,
evaluated by a simplified method, can predict mortality in an incident hemodialysis population.
Methodology/Principal Findings:We studied 119 patients with ESRD who had started hemodialysis three times weekly. ABI
was calculated by using two oscillometric blood pressure devices simultaneously. Patients were followed until death or the
end of the study. ABI was categorized in two groups normal (0.9–1.3) or abnormal (,0.9 and .1.3). There were 33 deaths
during a median follow-up of 12 months (from 3 to 24 months). Age (1 year) (hazard of ratio, 1.026; p = 0.014) and ABI
abnormal (hazard ratio, 3.664; p = 0.001) were independently related to mortality in a multiple regression analysis.
Conclusions: An easy and inexpensive technique to measure ABI was tested and showed to be significant in predicting
mortality. Both low and high ABI were associated to mortality in incident patients on hemodialysis. This technique allows
nephrologists to identify high-risk patients and gives the opportunity of early intervention that could alter the natural
progression of this population.
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Introduction
Despite significant technological advances, mortality among
patients on hemodialysis remains inexcusably high, particularly in
the first year of therapy [1].
One way to potentially reduce mortality is to alert medical staff
to patients at increased risk of death in order to facilitate timely
diagnostic and therapeutic interventions.
Hemodialysis patients are at an increased risk for atherosclerotic
disorders, including peripheral arterial disease (PAD) [2]. PAD is a
strong predictor for all-cause and cardiovascular mortality in
hemodialysis patients [3,4].
Ankle-brachial index (ABI) is a simple, noninvasive, and reliable
test for PAD screening. Usually ABI is classified as low (,0.9),
normal (0.9–1.3) and high (.1.3). Both low and high ABI are
correlated to high mortality in patients on hemodialysis [5]. Low
ABI is related to PAD, and high ABI is caused by no compressible
arteries and vascular calcification. Therefore, an abnormal ABI
value is a significant predictor of mortality among patients on
hemodialysis [4,6].
ABI was already identified as a predictor of mortality among
prevalent patients on hemodialysis. Incident patients on hemodi-
alysis are even at higher risk. The annual number of patients
beginning dialysis has grown, mostly because of the growing
prevalence of hypertension and diabetes, the main underlying
cause of kidney disease [7,8]. Most analyses of survival on dialysis
exclude the first 90-day period. There have been minimal
improvements in mortality rate during the first year, over the
past decade, even without including the initial 90 days [1,7]. ABI
could be an easy way to identify patients at the highest risk.
We recently tested measuring ABI by using two oscillometric
blood pressure devices simultaneously [9], simulating an ABI-form
device.
The results demonstrated good reproducibility and low intra-
observer variability. The ABI was extensively tested in three
consecutive dialysis sessions, as well as pre and post dialysis. The
question that remained was if this technique could be significant in
predicting mortality.
We therefore tested the general hypothesis that ABI measured
by two oscillometric blood pressure devices can predict mortality
in an incident hemodialysis population.
Methods
Subjects
Patients were enrolled from January 2008 to January 2010.
Inclusion criteria were patients with end-stage renal disease
(ESRD) at least 18 years of age undergoing their first month of
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conventional hemodialysis three times weekly in the University of
Sao Paulo School of Medicine’s Hospital das Clinicas. This was a
prospective observational study.
We excluded anyone who had been treated for infection, had
bilateral amputation, bilateral fistula or had atrial fibrillation. Prior
to ABI measurement, demographic characteristics, and medical
history were recorded. Biochemical data were measured within
2 weeks of ABI measurement and dialysis initiation.
ABI Measurement
The measurements were done by using two oscillometric
devices (Omron Corp 705 CP Corp, Tokyo, Japan) simultaneously
to measure blood pressure in the upper and lower extremities. The
pre dialysis ABI was used in this new technique which was already
intra-observer validated and described [9]. Briefly, measurements
were done pre dialysis, with the patient at rest in the supine
position, after 5 minutes of the beginning of the session. The
protocol was performed by the same examiner in all situations.
During the study, only raw blood pressure values were recorded,
and stored on a database for later ABI calculation. Our technique
showed that ABI can be measured by two oscillometric devices at
the same time, with good reproductibility and low intra-observer
variation.
Follow-up
The outcome of this study was all-cause mortality. Patients were
censored in case of renal transplantation or recovery of renal
function. Vital status was ascertained by telephone contact. The
censor date was 31st January 2010. Date of death was verified by
contacting relatives and/or the staff of the dialysis clinic. Survival
time was defined as the time of the baseline (first day of ABI
measurement) to the date of death or end of follow-up.
Ethic Statements
The protocol was approved by the Research Ethics Boards of
the University of Sao Paulo School of Medicine, and all subjects
provided written informed consent before participation.
Data Analysis
Differences between continuous variables and categorical
variables were calculated using Student t test for normally
distributed continuous variables and by Mann-Whitney U test
for abnormally distributed variables. The x2 or Fisher exact test
was used to compare nominal variables. To compare the 3 groups
according to ABI ,0.9, from 0.9 to 1.3 and .1.3, one-way
analysis of variance was applied, with Tukey post-hoc test.
Mortality was the outcome of the follow-up. The relation of ABI
categories and all-cause mortality was analyzed by Kaplan-Meier
survival plots and log-rank test. A stepwise multivariate cox
regression was undertaken to identify the relative risk of all-cause
mortality (entry threshold, P,0.05; removal threshold, P,0.10)
with the significant candidate variables (age, diabetes, calcium x
phosphorus product, parathyroid hormone and C-reactive pro-
tein). A lower level of the –2 log-likelihood indicates a better model
fit. Data are presented as means 6SD unless indicated otherwise.
A P-value ,0.05 was considered significant. Analyses were
performed with the use of SPSS 17.0.1 (SPSS Inc., Chicago, Ill).
Results
Subjects
Out of 123 consecutive ESRD patients, 4 lost the follow-up.
Therefore, 119 patients were studied (82 men and 37 women),
whose baseline characteristics were shown in Table 1. Diabetes,
hypertension and glomerulonephritis accounted for 80% of the
underlying causes of renal disease. The majority of the patients
had a family history of cardiovascular disease (51.2%), 30.2% were
smokers, 47.2% had diabetes, hypertension was found in almost
100% of the patients, and 77.3% presented sedentary behavior,
which configure in a high cardiovascular risk population. Anemia,
altered bone mineral metabolism, and inflammation (expressed by
C-reactive protein) were also observed.
Characteristics of the study population regarding ABI categories
(normal 0.9–1.3, low ,0.9, and high .1.3 are presented in
Table 2. Distribution of observed ABI at the baseline is shown in
Figure 1. The significant differences between these 3 groups were
age (p = 0.011), albumin (p= 0.040) and hemoglobin (p = 0.010).
Cardiovascular risk factors observed at the baseline were well
distributed among the three groups.
During the study there were 33 deaths on a median follow-up of
12 months (from 3 to 24 months). Table 3 shows the differences in
basal characteristics between the group of patients who died and
the group that survived. Patients who died were more likely to be
older (p = 0.003), and with lower PTH (p= 0.044). Gender,
diabetes, family history of cardiovascular disease, smoking and
sedentary habitus, blood pressure, and biochemical variables did
not distinguish survivors and non-survivors. The ABI as a
continuous variable was virtually identical in survivors and non-
survivors (p = 0.998). However, abnormal ABI was more frequent
among patients who died than in patients who survived (63.6% vs.
13.9%, p,0.0001).
Table 1. Characteristics of the study population.
Variables N=119
Age, years 53.1618.8
Male, n (%) 82 (68.9)
Etiology of ESRD, n (%)
Hypertension 35 (29.4)
Diabetes 44 (37.0)
Glomerulonephritis 18 (15.1)
Others 22 (18.5)
Hypertension, n (%) 118 (99.1)
Diabetes mellitus, n (%) 49 (47.2)
Family history of CV disease, n (%) 62 (52.1)
Smoking, ever vs. never, n (%) 36 (30.2)
Sedentary habits, n (%) 92 (77.3)
Ankle-brachial index 1.1660.23
Systolic Blood Pressure, mmHg 149.4623.8
Diastolic Blood Pressure, mmHg 85.9617.2
Albumin level, g/dl 3.460.7
Phosphorus level, mg/dl 5.862.2
Calcium corrected, mg/dl 9.061.1
Calcium x Phosphorus, mg/dl 48.3618.3
Total cholesterol, mg/dl 167.9644.9
Hemoglobin, g/dl 9.361.7
C-reactive protein, mg/L 35.9648.9
Parathyroid hormone, pg/ml 372.76484.2
CV, cardiovascular; Calcium corrected = calcium + (4-albumin)60.8.
Values are expressed as mean 6 SD or n (percentage).
doi:10.1371/journal.pone.0042290.t001
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Figure 2 shows an unadjusted Kaplan-Meier survival curve
analysis demonstrating that abnormal ABI was associated with
greater all-cause mortality. The mean survival time and 95%
confidence interval was 21.160.8 months (19.6–22.6) for normal
ABI, and 16.261.2 months (13.8–18.7) for abnormal ABI; log-
rank test p = 0.0001.
Upon multivariable Cox regression analyses of all-cause
mortality by forward stepwise, the association between abnormal
ABI and mortality remained. The HR associated with abnormal
ABI was 3.664 times higher than normal ABI (p = 0.001, 95% CI,
1.708–7.861) (Table 4).
Discussion
Our study has given rise to important findings that provide
novel possibilities into the diagnostic and interventions in an
incident population on hemodialysis. We found that abnormal
baseline ABI can predict mortality in hemodialysis patients. In
addition, we accessed ABI by a simple and easy method. These
findings suggest that ABI may be measured at patient’s entry on
hemodialysis therapy, even in centers without Doppler or an ABI-
form device.
Our study population was representative of the total dialysis
population in Brazil, according to the Brazilian Society of
Nephrology [10,11] in terms of age, gender distribution and cause
Table 2. Characteristics of the study population according to ABI.
Variable ABI
,0.9 N=12 0.9–1.3 N=73 .1.3 N=34 p
Age, years 68.8616.6* 53.7617.9 42.3618.2 0.001
Male sex, n (%) 7 (58.3) 49 (67.1) 26 (76.5) 0.440
Diabetes mellitus, n (%) 5 (41.7) 29 (39.7) 15 (44.1) 0.911
Family history of CV disease, n (%) 6 (50) 41 (56.2) 15 (44.1) 0.503
Smoking, ever vs. never, n (%) 4 (33) 23 (31.5) 9 (26.5) 0.844
ABI 0.6860.16* 1.1360.11 1.4060.08* 0.0001
Albumin level, g/dl 3.460.9 3.560.6 3.160.8* 0.040
Calcium x Phosphorus, mg2/dl2 47.7622.0 49.7618.6 45.6616.6 0.564
Total cholesterol, mg/dl 162.4636.8 168.3646.9 169.1643.9 0.903
Hemoglobin, g/dl 9.962,1 9.561.6 8.661.5* 0.010
C-reactive protein, mg/l 55.0669.8 31.0641.3 39.6654.9 0.260
Parathyroid hormone, pg/ml 463.66302.1 397.76555.7 286.26360.4 0.448
CV, cardiovascular; ABI, ankle-brachial index; Corrected Calcium = calcium + (4-albumin)60.8.
Values are expressed as Mean 6 SD. *p,0.05 by post-test, comparing to ABI 0.9–1.3.
doi:10.1371/journal.pone.0042290.t002
Figure 1. Frequency distribution of baseline ankle-brachial index (ABI).
doi:10.1371/journal.pone.0042290.g001
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of ESRD. The prevalence of diabetes is also similar to the
American and European reports [7,12,13]. However, all these
data refer to the prevalent population and we studied an incident
population. This specific population has an even higher risk of
mortality. Some reported annual rate of mortality simply does not
take into account the first 3 months of hemodialysis. The lack of
information in the literature regarding diagnostic and possible
therapeutic interventions in this selected population calls for new
studies.
The incidence of patients in hemodialysis has increased in
Brazil. The estimated number of patients starting treatment in
2010 was 18,972 (incidence rate: 99.5/million) [11].
We demonstrated that our sample size of incident patients on
hemodialysis is at a high risk of mortality, with a family history of
cardiovascular events, sedentary and smoking habits, presence
almost universal of hypertension, diabetes and all dialysis-related
biochemical abnormalities also associated to the high mortality
risk. Indeed, we observed that 27.7% of the entire population had
died after a 2-year period of follow-up.
The present data build on the previous findings showing that
ABI is a good tool to detect high risk patients on hemodialysis.
However, a mainly prevalent population on hemodialysis was
studied, showing that both low and high ABI were associated to
high overall and cardiovascular mortality [4,5,14,15].
Table 3. Survivors and non-survivors.
Variable Survivors N=86 Non-survivors N=33 p
Age, years 50.0618.3 61.2617.8 0.003
Male sex, n (%) 58 (67.4) 27 (81.8) 0.671
Diabetes mellitus, n (%) 31 (36.0) 19 (57.6) 0.161
Family history of CV disease, n (%) 44 (51.2) 19 (57.6) 1
Smoking, ever vs. never, n (%) 26 (30.2) 10 (30.3) 0.830
Sedentary habitus, n (%) 68 (79.1) 26 (78.8) 0.355
ABI 1.1660.18 1.1560.32 0.998
Abnormal ABI, % 13.9 63.3 ,0.0001
Systolic BP, mmHg 150.5625.4 148.7624.0 0.735
Diastolic BP, mmHg 86.9619.9 81.0616.9 0.146
Albumin level, g/dl 3.560.6 3.260.8 0.104
Calcium x Phosphorus, mg2/dl2 50.2619.2 43.5615.1 0.195
Total cholesterol, mg/dl 168.5640.5 166.3655.3 0.810
Hemoglobin, g/dl 9.261.8 9.4613 0.612
C-reactive protein, mg/l 29.5639.6 52.8665.5 0.071
Parathyroid hormone, pg/ml 412.06549.1 266.56203.5 0.044
CV, cardiovascular disease; ABI, ankle-brachial index.
Values are expressed as Mean 6 SD.
doi:10.1371/journal.pone.0042290.t003
Figure 2. Kaplan-Meier survival curves according to ABI categories: normal (0.9–1.3) or abnormal (,0.9 and .1.3). A lower risk of
mortality was observed for normal ABI [superior dashed line]; A higher risk of mortality was observed for abnormal ABI [continuous line]. Log-rank
p = 0.0003;
doi:10.1371/journal.pone.0042290.g002
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We could demonstrate similar results of previous studies by
using a modified method in measuring ABI. It is important,
however, to emphasize, that we had previously tested the intra-
observer reproducibility. Based on this, we may suggest the use of
this simple technique but we not guarantee applicability to other
dialysis population. Different from previous studies, we accessed
patients within their first month of dialysis. This approach allows
us early recognition of patients at high risk of mortality.
The critical question is if the use of our simple technique in
detecting abnormal ABI can eventually improve outcomes. There
is no indication whether or not knowing the prognosis will improve
outcomes. Possibly, we can at least alert medical staff to implement
therapeutic interventions in those patients with abnormal ABI.
Nevertheless, the clinical utility of our technique has to be studied
rigorously in further studies. These studies should enrol larger
sample sizes and evaluate different examiners measuring ABI.
Our study is subject to some limitations. First, it only shows
associations between abnormal ABI and mortality in one selected
dialysis population; this may not be applicable to all hemodialysis
population. Second, the sample size was small. Third, we did not
compare our technique to the gold-standard method, Doppler, in
order to prove they can be interchangeable, although this was not
an objective of the present data. Forth, we had no access to
medication in use and dose of dialysis during the follow-up period.
Finally, we could not distinguish between overall and cardiovas-
cular cause of mortality, because the lack of accurate information
relevant to the deaths of the patients within the study population.
However, our method was extensively tested and validated
previously, and although we examined a small sample size, a direct
relationship between abnormal ABI and mortality was found.
In conclusion, these data suggest that abnormal ABI was
associated with increased mortality among incident patients on
hemodialysis. The ABI could be measured by using at the same
time two oscillometric blood pressure devices and then, making an
easier and more largely applicable method in detecting patients
with the highest risk of mortality. Our results also suggest the need
for randomized trials to determine whether more aggressive
interventions will change the outcomes.
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